108 Days
Source:
الصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
108 Daysالصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
108 DaysReady to play
Ready to play
A study conducted by the University of Montreal has revealed that the common medication used to treat Type 2 diabetes, metformin, directly targets the ATP5I molecule in the mitochondria. This discovery explains how metformin contributes to reducing the risk of cancer, and its potential effects may extend to lifespan extension, in addition to its role in energy metabolism and cellular biology. The study suggests that understanding this mechanism could open new avenues for treatments focused on the ATP5I target.
Notice: This Is an AI-Generated Summary
Comments (0)